Blurbs

Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (MOH), Laboratory (LH) and Amedisys (AMED)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molina Healthcare (MOHResearch Report), Laboratory (LHResearch Report) and Amedisys (AMEDResearch Report).

Molina Healthcare (MOH)

Deutsche Bank analyst George Hill maintained a Hold rating on Molina Healthcare on July 29 and set a price target of $315.00. The company’s shares closed last Friday at $327.72.

According to TipRanks.com, Hill is a 5-star analyst with an average return of 7.3% and a 56.3% success rate. Hill covers the Healthcare sector, focusing on stocks such as AmerisourceBergen, 1Life Healthcare, and Cardinal Health.

Currently, the analyst consensus on Molina Healthcare is a Hold with an average price target of $334.30, a 5.1% upside from current levels. In a report issued on July 14, Jefferies also maintained a Hold rating on the stock with a $309.00 price target.

See the top stocks recommended by analysts >>

Laboratory (LH)

In a report issued on July 28, Pito Chickering from Deutsche Bank maintained a Hold rating on Laboratory, with a price target of $265.00. The company’s shares closed last Friday at $262.19.

According to TipRanks.com, Chickering is a 3-star analyst with an average return of 1.4% and a 43.1% success rate. Chickering covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Bausch + Lomb Corporation, and Zimmer Biomet Holdings.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Laboratory with a $299.00 average price target.

Amedisys (AMED)

Deutsche Bank analyst Justin Bowers maintained a Buy rating on Amedisys yesterday and set a price target of $175.00. The company’s shares closed last Friday at $119.85, close to its 52-week low of $101.61.

According to TipRanks.com, Bowers is a 4-star analyst with an average return of 9.0% and a 52.4% success rate. Bowers covers the Healthcare sector, focusing on stocks such as Select Medical, IQVIA Holdings, and Icon.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Amedisys with a $149.42 average price target, representing a 22.5% upside. In a report issued on July 28, Benchmark Co. also maintained a Buy rating on the stock with a $165.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on MOH:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
Videos

Latest News Feed